Sphera Funds Management Ltd. Fulcrum Therapeutics, Inc. Transaction History
Sphera Funds Management Ltd.
- $486 Million
- Q4 2024
A detailed history of Sphera Funds Management Ltd. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Sphera Funds Management Ltd. holds 59,000 shares of FULC stock, worth $217,710. This represents 0.05% of its overall portfolio holdings.
Number of Shares
59,000Holding current value
$217,710% of portfolio
0.05%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding FULC
# of Institutions
134Shares Held
52.8MCall Options Held
3.08MPut Options Held
316K-
Ra Capital Management, L.P. Boston, MA10.2MShares$37.7 Million0.78% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$19.4 Million4.03% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$17.7 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.78MShares$17.6 Million1.13% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.34MShares$12.3 Million0.65% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $192M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...